CA2856609C - Process for the preparation of sterol derivatives - Google Patents
Process for the preparation of sterol derivatives Download PDFInfo
- Publication number
- CA2856609C CA2856609C CA2856609A CA2856609A CA2856609C CA 2856609 C CA2856609 C CA 2856609C CA 2856609 A CA2856609 A CA 2856609A CA 2856609 A CA2856609 A CA 2856609A CA 2856609 C CA2856609 C CA 2856609C
- Authority
- CA
- Canada
- Prior art keywords
- beta
- alpha
- hydroxy
- acetoxy
- aminopropylamino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306548.6 | 2011-11-24 | ||
| EP11306548 | 2011-11-24 | ||
| PCT/EP2012/073489 WO2013076257A1 (en) | 2011-11-24 | 2012-11-23 | Process for the preparation of sterol derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2856609A1 CA2856609A1 (en) | 2013-05-30 |
| CA2856609C true CA2856609C (en) | 2021-01-12 |
Family
ID=47216329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2856609A Active CA2856609C (en) | 2011-11-24 | 2012-11-23 | Process for the preparation of sterol derivatives |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US9447141B2 (2) |
| EP (1) | EP2782923B1 (2) |
| JP (1) | JP6157492B2 (2) |
| KR (1) | KR20140098131A (2) |
| CN (1) | CN104039807B (2) |
| AU (1) | AU2012342460B2 (2) |
| BR (1) | BR112014012458A2 (2) |
| CA (1) | CA2856609C (2) |
| ES (1) | ES2613753T3 (2) |
| IN (1) | IN2014MN00976A (2) |
| MX (1) | MX343787B (2) |
| RU (1) | RU2014125435A (2) |
| WO (1) | WO2013076257A1 (2) |
| ZA (1) | ZA201403736B (2) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10669296B2 (en) | 2014-01-10 | 2020-06-02 | Rgenix, Inc. | LXR agonists and uses thereof |
| CA3010883A1 (en) | 2016-01-11 | 2017-07-20 | The Rockefeller University | Methods for the treatment of myeloid derived suppressor cells related disorders |
| FR3064470A1 (fr) * | 2017-03-31 | 2018-10-05 | Lessonia | Masque ou patch prepare a partir d’une composition d’alginate |
| EP3713575A4 (en) | 2017-11-21 | 2021-08-25 | Rgenix, Inc. | POLYMORPHS AND THEIR USES |
| WO2020061317A1 (en) * | 2018-09-19 | 2020-03-26 | Modernatx, Inc. | Sterol purification |
| BE1027157B9 (fr) * | 2019-08-01 | 2020-11-03 | Dendrogenix | Composition de dérivés de stérols pour son utilisationdans le traitement d’une pathologie neuronale liée à une hypoxie et/ou à une hypoglycémie et composition correspondante |
| HUE067466T2 (hu) | 2019-12-13 | 2024-10-28 | Inspirna Inc | Fémsók és alkalmazásuk |
| JP7849051B2 (ja) * | 2020-10-29 | 2026-04-21 | デンドロゲニックス | 癌の治療に使用するための5α-ヒドロキシ-6β-[2-(1H-イミダゾール-4-イル)エチルアミノ]-コレスタン-3β-オール類似体およびそれを含む医薬組成物 |
| BE1028852B1 (fr) * | 2020-12-03 | 2022-07-05 | Dendrogenix | PRODROGUE DU 5α-hydroxy-6β-[2-(1H-imidazol-4-yl) éthylamino]cholestan-3β-ol ET COMPOSITIONS PHARMACEUTIQUES LE COMPRENANT POUR UTILISATION DANS LE TRAITEMENT DU CANCER |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2838741B1 (fr) | 2002-04-19 | 2006-01-27 | Inst Nat Sante Rech Med | Derives de sterols, leur procede de preparation et medicaments les comportant |
-
2012
- 2012-11-23 KR KR1020147016187A patent/KR20140098131A/ko not_active Withdrawn
- 2012-11-23 ES ES12788589.5T patent/ES2613753T3/es active Active
- 2012-11-23 IN IN976MUN2014 patent/IN2014MN00976A/en unknown
- 2012-11-23 JP JP2014542857A patent/JP6157492B2/ja active Active
- 2012-11-23 US US14/359,658 patent/US9447141B2/en active Active
- 2012-11-23 CA CA2856609A patent/CA2856609C/en active Active
- 2012-11-23 CN CN201280065737.0A patent/CN104039807B/zh active Active
- 2012-11-23 WO PCT/EP2012/073489 patent/WO2013076257A1/en not_active Ceased
- 2012-11-23 MX MX2014006303A patent/MX343787B/es active IP Right Grant
- 2012-11-23 AU AU2012342460A patent/AU2012342460B2/en active Active
- 2012-11-23 RU RU2014125435/04A patent/RU2014125435A/ru not_active Application Discontinuation
- 2012-11-23 EP EP12788589.5A patent/EP2782923B1/en active Active
- 2012-11-23 BR BR112014012458A patent/BR112014012458A2/pt not_active IP Right Cessation
-
2014
- 2014-05-22 ZA ZA2014/03736A patent/ZA201403736B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN104039807B (zh) | 2018-02-13 |
| JP6157492B2 (ja) | 2017-07-05 |
| KR20140098131A (ko) | 2014-08-07 |
| JP2015502934A (ja) | 2015-01-29 |
| US20140309417A1 (en) | 2014-10-16 |
| RU2014125435A (ru) | 2015-12-27 |
| WO2013076257A1 (en) | 2013-05-30 |
| IN2014MN00976A (2) | 2015-04-24 |
| ZA201403736B (en) | 2015-11-25 |
| MX343787B (es) | 2016-10-31 |
| BR112014012458A2 (pt) | 2017-06-06 |
| EP2782923A1 (en) | 2014-10-01 |
| CN104039807A (zh) | 2014-09-10 |
| ES2613753T3 (es) | 2017-05-25 |
| CA2856609A1 (en) | 2013-05-30 |
| EP2782923B1 (en) | 2016-11-23 |
| MX2014006303A (es) | 2014-09-08 |
| AU2012342460A1 (en) | 2014-06-12 |
| US9447141B2 (en) | 2016-09-20 |
| AU2012342460B2 (en) | 2017-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2856609C (en) | Process for the preparation of sterol derivatives | |
| US8163933B2 (en) | Clean, high-yield preparation of S,S and R,S amino acid isosteres | |
| KR100286874B1 (ko) | 보호된 4-아미노메틸-피롤리딘-3-온의 제조방법 | |
| CN111646964B (zh) | 一种碱催化的合成2h-吡喃-2-酮衍生物新方法 | |
| CN102199180B (zh) | 一种卡培他滨的制备方法 | |
| JP6816274B2 (ja) | (s)−n1−(2−アミノエチル)−3−(4−アルコキシフェニル)プロパン−1,2−ジアミン三塩酸塩の製造方法 | |
| US11780818B2 (en) | Methods of making delmopinol and salts thereof | |
| CN112824381B (zh) | 一种哌啶胺的制备方法 | |
| EP1547993A1 (en) | Process for preparation of spirofluorenols | |
| CN113717197B (zh) | 抗结核药物Pretomanid的制备方法及其应用 | |
| JP2026501936A (ja) | リンカー薬物複合体の調製方法及びその中間体 | |
| CN109574860B (zh) | 一种制备维兰特罗的方法 | |
| KR101628946B1 (ko) | 실로도신의 개선된 제조방법 | |
| CN111943893A (zh) | 4,7-二氮杂螺[2.5]辛烷类化合物的合成方法 | |
| CN121202755A (zh) | 一种螺环中间体化合物及其合成方法 | |
| CN120590331A (zh) | 一种(2s,6s)-2,6-二甲基-1-哌嗪羧酸叔丁酯的制备方法 | |
| CN120887846A (zh) | 一种6-羟基苯并吗啉的合成方法 | |
| JP2022035954A (ja) | N-Boc-ラクタム誘導体及びその製造方法、並びに、環状アミン誘導体の製造方法 | |
| CN105622459B (zh) | 一种制备打碗花精及其中间体的方法 | |
| KR20030055304A (ko) | 보호된 1-(1-아미노알킬)-옥시란의 제조 방법 | |
| HK40099433A (en) | Methods for producing (6s,15s)-3,8,13,18-tetraazaicosane-6,15-diol | |
| JP2024080578A (ja) | ミラベグロン及びその製造中間体の製造方法 | |
| CN118063328A (zh) | 一种2,3-二溴-1-丙胺盐的高效低成本制备方法 | |
| CN118812387A (zh) | 一种索他洛尔中间体化合物 | |
| CN111943894A (zh) | 一种4,7-二氮杂螺[2.5]辛烷类化合物的合成方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20171101 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20241114 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250530 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20251023 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20251023 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R11-R127 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER RECORDAL REQUEST OR RESPONSE Effective date: 20260219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260219 |
|
| R14 | Transfer of ownership recorded |
Free format text: ST27 STATUS EVENT CODE: A-4-4-R10-R14-R129 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: TRANSFER REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260407 |